Cabozantinib is a multi-target broad-spectrum anticancer drug that can inhibit at least nine targets, including MET, VEGFR1/2/3, ROS1, RET, AXL, NTRK, KIT, etc. At present, cabozantinib has been proven to have good therapeutic effects in a variety of solid tumors, including renal cancer, thyroid cancer, liver cancer, soft tissue sarcoma, non-small cell lung cancer, prostate cancer, breast cancer, ovarian cancer, and intestinal cancer, and its control effect on bone metastasis is particularly outstanding. Due to its wide effectiveness against a variety of cancers, cabozantinib is called the "panacea" among targeted drugs, with broad-spectrum anti-cancer capabilities.

Cabozantinib price

Can I buy cabozantinib in China?

Formal channels for targeted drugs in India